284 related articles for article (PubMed ID: 31400507)
1. Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet).
Li H; Cao X; Liu Y; Liu T; Wang M; Ren X; Dou Z
J Ethnopharmacol; 2019 Nov; 244():112148. PubMed ID: 31400507
[TBL] [Abstract][Full Text] [Related]
2. Analysis of five active ingredients of Er-Zhi-Wan, a traditional Chinese medicine water-honeyed pill, using the biopharmaceutics classification system.
Cao X; Li H; Wang M; Ren X; Deng Y
Biomed Chromatogr; 2020 Feb; 34(2):e4757. PubMed ID: 31755125
[TBL] [Abstract][Full Text] [Related]
3. [Biopharmaceuticals classification system(BCS) of nuciferin in Nelumbinis Folium].
Zhao JR; Ren XL; Wang M
Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(3):511-519. PubMed ID: 29600615
[TBL] [Abstract][Full Text] [Related]
4. Identify super quality markers from prototype-based pharmacokinetic markers of Tangzhiqing tablet (TZQ) based on in vitro dissolution/ permeation and in vivo absorption correlations.
Li Z; Liu J; Li Y; Du X; Li Y; Wang R; Lv C; He X; Wang B; Huang Y; Zhang D
Phytomedicine; 2018 Jun; 45():59-67. PubMed ID: 29685365
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
Jantratid E; Prakongpan S; Amidon GL; Dressman JB
Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
[TBL] [Abstract][Full Text] [Related]
6. Nuciferine and paeoniflorin can be quality markers of Tangzhiqing tablet, a Chinese traditional patent medicine, based on the qualitative, quantitative and dose-exposure-response analysis.
Li Z; Liu J; Zhang D; Du X; Han L; Lv C; Li Y; Wang R; Wang B; Huang Y
Phytomedicine; 2018 May; 44():155-163. PubMed ID: 29519686
[TBL] [Abstract][Full Text] [Related]
7. Matrix effects of the hydroethanolic extract and the butanol fraction of calyces from Physalis peruviana L. on the biopharmaceutics classification of rutin.
Domínguez Moré GP; Feltrin C; Brambila PF; Cardona MI; Echeverry SM; Simões CMO; Aragón DM
J Pharm Pharmacol; 2020 May; 72(5):738-747. PubMed ID: 32162346
[TBL] [Abstract][Full Text] [Related]
8. [Biopharmaceutics classification and absorption mechanisms primary study on four kinds of flavonoids].
Li HF; Zhang D; Qu WJ; Wang HL; Liu Y; Borjigdai A; Cui J; Dong ZQ
Zhongguo Zhong Yao Za Zhi; 2016 Apr; 41(7):1198-1203. PubMed ID: 28879731
[TBL] [Abstract][Full Text] [Related]
9. [Research and development thought on biopharmaceutics classification system of Chinese materia medica].
Liu Y; Wang ZY; Xu WJ; Zhang CJ; Dong L
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3637-3644. PubMed ID: 31602935
[TBL] [Abstract][Full Text] [Related]
10. The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.
Charalabidis A; Sfouni M; Bergström C; Macheras P
Int J Pharm; 2019 Jul; 566():264-281. PubMed ID: 31108154
[TBL] [Abstract][Full Text] [Related]
11. Establishing the pharmaceutical quality of Chinese herbal medicine: a provisional BCS classification.
Fong SY; Liu M; Wei H; Löbenberg R; Kanfer I; Lee VH; Amidon GL; Zuo Z
Mol Pharm; 2013 May; 10(5):1623-43. PubMed ID: 23473440
[TBL] [Abstract][Full Text] [Related]
12. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.
Tsume Y; Mudie DM; Langguth P; Amidon GE; Amidon GL
Eur J Pharm Sci; 2014 Jun; 57():152-63. PubMed ID: 24486482
[TBL] [Abstract][Full Text] [Related]
13. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
[TBL] [Abstract][Full Text] [Related]
14. [Overall intestinal permeability of multiple components in lotus leaves].
Hou CB; Dong YL; Yin XW; Liu Y; Sun HJ; Chen YY; Dong L
Zhongguo Zhong Yao Za Zhi; 2016 Apr; 41(7):1183-1187. PubMed ID: 28879728
[TBL] [Abstract][Full Text] [Related]
15. Integrating theoretical and experimental permeability estimations for provisional biopharmaceutical classification: Application to the WHO essential medicines.
Cabrera-Pérez MÁ; Pham-The H; Cervera MF; Hernández-Armengol R; Miranda-Pérez de Alejo C; Brito-Ferrer Y
Biopharm Drug Dispos; 2018 Jul; 39(7):354-368. PubMed ID: 30021059
[TBL] [Abstract][Full Text] [Related]
16. Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic models.
Hansmann S; Darwich A; Margolskee A; Aarons L; Dressman J
J Pharm Pharmacol; 2016 Dec; 68(12):1501-1515. PubMed ID: 27781273
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.
Parr A; Hidalgo IJ; Bode C; Brown W; Yazdanian M; Gonzalez MA; Sagawa K; Miller K; Jiang W; Stippler ES
Pharm Res; 2016 Jan; 33(1):167-76. PubMed ID: 26286187
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of two in vitro methods for assessing drug absorption: Sartorius SM 16750 apparatus versus Everted Gut Sac.
Lassoued MA; Khemiss F; Sfar S
J Pharm Pharm Sci; 2011; 14(1):117-27. PubMed ID: 21501558
[TBL] [Abstract][Full Text] [Related]
19. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
[TBL] [Abstract][Full Text] [Related]
20. Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs.
Zhang SY; Ong WSY; Subelzu N; Gleeson JP
Int J Pharm; 2024 May; 656():124089. PubMed ID: 38599444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
